181 |
Einfluss der Kollagenrezeptoren ITGA2 und DDR1 in der Pathogenese von glomerulären Nierenerkrankungen am Doppelknockout-Tiermodell / The role of collagen-receptors ITGA2 and DDR1 in the pathogenesis of glomerular defects investigated in double knockout animal modelLeibnitz, Alexander 20 May 2014 (has links)
Die Mehrheit chronischer Nierenerkrankungen wird durch glomeruläre Defekte hervorgerufen. In dieser Arbeit wurde deshalb im Mausmodell die Bedeutung der Kollagenrezeptoren DDR1 (Discoidin Domain Rezeptor 1) und ITGA2 (Integrin Alpha 2) in der Pathogenese von glomerulären Nierenerkrankungen untersucht. Von zentralem Interesse waren neben der Betrachtung des renalen Phänotyps, die Analyse der glomerulären Basalmembran sowie die Prüfung auf Vorhandensein nierenschädigender Faktoren. Zur Orientierung angefertigte H.E.-Färbungen waren lichtmikroskopisch unauffällig, jedoch ließ sich mittels Gelelektrophorese eine Mikro-, Makro- und Albuminurie mit einem Maximum zum Zeitpunkt von 100 Lebenstagen nachweisen, die mit 200 Tagen wieder stark sank. Auf dem Boden der nierenschädigenden Proteinurie, zeigten die Western-Blot-Analysen das Vorhandensein der Zytokine TGF-ß und CTGF auf. Die zur Detektion von Narbengewebe durchgeführte Fibronektinfärbung, erbrachte keinerlei weiterführende Anhaltspunkte. In der Elektronenmikroskopie ließ sich vereinzelt eine Mehrschichtung der GBM nachweisen, was als Ausreifungsstörung interpretiert wurde. Der Wegfall der beiden Kollagenrezeptoren ITGA2 und DDR1 scheint somit die Interaktion der Podozyten mit der GBM zu stören. Dies hat eine Proteinurie zur Folge. In Folge dessen werden profibrotische Zytokine sezerniert. Das Fehlen der beiden Kollagenrezeptoren DDR1 und ITGA2 führte jedoch nicht zur Ausbildung einer renalen Fibrose, wie in der Fibronektin-Färbung gezeigt werden konnte. Gross und Girgert zeigten, dass nierenkranke Mäuse nach dem Verlust von DDR1 oder ITGA2 einen verzögerten Verlauf der Nierenfibrose entwickelten. Vielversprechend scheinen Untersuchungen z.B. am Mausmodell Col4A3/DDR1/ITGA2 -/- oder an einer diabetischen ITGA2/DDR1 -/- Maus. Gesetzt dem Fall, dass eine renale Fibrose im Vergleich zum Einzelknockout noch später eintritt, eignen sich diese beiden Kollagenrezeptoren als therapeutisches Ziel. Aktuell stehen nur wenige nephroprotektive Medikamente, wie ACE-Hemmer, zur Verfügung. Anti-Integrine und Inhibitoren gegen Tyrosinkinase-Rezeptoren, wie DDR1, haben bereits Einzug in den klinischen Alltag gehalten und stellen eventuell einen wirksamen Ansatzpunkt zur Verhinderung einer renalen Fibrose dar.
|
182 |
Vliv složek extracelulární matrix na buňky kultivované in vitro / The Influence of Extracellular Matrix Components to Cells Cultured In VitroPeterová, Eva January 2017 (has links)
Myofibroblast expansion is a critical event in the pathogenesis of liver fibrosis. The activation of hepatic stellate cells (HSC) to myofibroblast (MFB) results in the enhanced production of extracellular matrix (ECM). We have studied the effect of fibroblast growth factor 1 (FGF-1) on liver MFB. In the second part we investigated effect of transforming growth factor β1 (TGF-β1) and FGF-1 on cell line HSC-T6. Cells were cultured on plastic dishes and in 3D collagen gel mimicking fibrotic tissue. MFB were isolated by repeated passaging of nonparenchymal liver cell fraction. The transfer of MFB from plastic dishes to collagen gel resulted in the change in their shape and phenotype. The expression of cytokine TGF-β1 and of MFB markers, α-smooth muscle actin (α-SMA) and cellular fibronectin (EDA-FN) on protein level was significantly decreased in collagen gel. The experiments with SB 431542, the inhibitor of TGF-β receptor type I, showed that EDA-FN and α-SMA are differently regulated. EDA-FN expression is dependent on TGF-β1, while the expression of α-SMA is primarily determined by the environment and modified by TGF-β1. EDA-FN is more sensitive to the U0126, the inhibitor of protein kinases MEK 1 and 2. Collagen gel does not change the expression of metalloproteinase MMP-2 but activates the proenzyme....
|
183 |
Avaliação de alterações morfológicas da pele após lesão radioinduzida em ratos Wistar / Evaluation of skin morphological alterations after radio induced injury in Winstars ratsCherley Borba Vieira de Andrade 25 February 2010 (has links)
Comissão Nacional de Energia Nuclear / A radioterapia é uma das modalidades terapêuticas mais utilizadas no tratamento do câncer, visando à destruição das células neoplásicas, a partir da utilização de radiação ionizante. Um dos fatores limitantes da radioterapia é o dano em tecidos sadios vizinhos ao tumor. A irradiação da pele, acidental ou para fins terapêuticos, pode desencadear uma série de lesões culminando na fibrose, o que implica na alteração funcional deste órgão. A avaliação dos efeitos morfológicos associados à irradiação da pele torna-se fundamental para estabelecer estratégias de irradiação mais eficazes e diminuição da morbidade; e em caso de acidentes, adequado manuseio da vítima. O objetivo deste estudo foi avaliar as alterações dérmicas radioinduzidas, utilizando um modelo em ratos. Ratos Wistar, machos, com três meses de idade, tiveram sua pele irradiada, em um campo de 3cm2, com doses únicas de 10, 40 e 60 Gy de elétrons com energia nominal de 4MeV. Após a irradiação, os animais permaneceram sob avaliação constante, sendo as lesões registradas fotograficamente. Os animais foram divididos em grupos e eutanasiados: no dia da irradiação, 5, 10, 15, 25 e 100 dias após a irradiação. Parte da pele foi fixada em formaldeído, incluída em parafina e submetida à microtomia. Os cortes foram corados com hematoxilina-eosina, picrosirius red e imunomarcados com anticorpo anti-TGF-beta1. Outra parte do tecido foi fixada em glutaraldeido e processada para microscopia eletrônica de varredura. Foi observado macroscopicamente o surgimento de lesões cutâneas semelhantes a queimaduras em toda área irradiada. Ao microscópio óptico foi verificado o inicio de desenvolvimento de lesão 5 dias após irradiação. Decorridos 10 dias da irradiação observou-se indícios de cicatrização epidérmica abaixo da crosta formada pela lesão. Aos 15 dias após a irradiação o tecido abaixo da lesão apresentava epiderme reconstruída e características de cicatrização tecidual. Foi visualizado também um infiltrado de polimorfonucleares significativo. Após 25 dias nas doses mais elevadas as lesões persistiam, o que não ocorreu na menor dose, na qual a área irradiada dos animais já se encontrava completamente cicatrizada. Após 100 dias da irradiação na dose de 40 Gy ocorreu a cicatrização da ferida. Na dose de 60 Gy em alguns animais a lesão persistia. Nos animais em que ocorreu a cicatrização houve uma hipertrofia da epiderme (acantose). Foi visualizado um tecido com aspecto morfológico totalmente descaracterizado, e necrosado. Os resultados encontrados na analise através de microscopia eletrônica de varredura corroboram os dados encontrados na microscopia de luz, onde observou-se a descaracterização das fibras de colágeno nas doses mais elevadas. Os resultados indicam que as doses utilizadas induziram um processo inflamatório importante na pele, ativando o sistema imunológico. Este fato promoveu um aumento na expressão do TGFbeta1, um dos responsáveis pelo aumento da produção da matriz extracelular por vários tipos celulares, principalmente por fibroblastos em tecidos lesionados. Alem do aumento de expressão da MEC, o TGFbeta1 também promove a inibição dos processos de degradação da mesma. A intensa expressão desta citocina na pele irradiada pode desencadear o processo de fibrose e, conseqüentemente, afetar a homeostase deste órgão devido ao acúmulo da MEC. / Radiation therapy is one of the most commonly used therapeutic modalities in cancer treatment, aiming the destruction of neoplastic cells using ionizing radiation. A limiting factor is the radiation damage in healthy tissues neighboring the tumor. The irradiation of the skin, accidentally or for therapeutic purposes, can trigger a series of injuries culminating in fibrosis, causing functional alterations in this organ. The morphological evaluation of the effects associated with skin irradiation becomes essential to establish more effective strategies for irradiation and decreased morbidity, and in case of accidents, proper handling of the victim. The aim of this study was to evaluate the radiation-induced dermal changes, using a rats model. Male Wistar rats, three months old, had their skin irradiated, in a 3cm2 field, with single doses of 10, 40 and 60 Gy of electrons with nominal energy of 4MeV. After irradiation, the animals were kept under constant observation, lesions were recorded photographically. The animals were divided into groups and euthanized: on the day of irradiation, 5, 10, 15, 25 and 100 days after irradiation. Part of the skin was fixed in formaldehyde, embedded in paraffin and subjected to microtomy. Sections were stained with hematoxylin-eosin, picrosirius red and immunostained with anti-TGF-beta1. Another part of the tissue was fixed in glutaraldehyde and processed for scanning electron microscopy. It was observed macroscopic skin lesions similar to burns throughout the irradiated area. It was verified, by optical microscopy, the early development of lesions 5 days after irradiation. After 10 days of irradiation there was evidence of epidermal wound healing under the crust formed by the injury. At the day 15 days the tissue below the lesion was reconstructed and had characteristics of healing, displaying a significant polymorphonuclear cells infiltration. After 25 days, at the higher doses, the lesions persisted, which did not occur at the lowest dose, which the irradiated area was already completely healed. After 100 days of irradiation with 40 Gy the wound was healed. With 60 Gy, in some animals, the lesion persisted. In the animals which the healing took place there was a hypertrophy of the epidermis (acanthosis). It was observed a tissue totally morphological mischaracterized, and necrotic. The results obtained by scanning electron microscopy analysis corroborate with the optical microscopy findings, where the higher doses collagen fibers were mischaracterized. The results indicate that the doses used induced a significant inflammation in the skin, activating the immune system. This fact promoted an increased expression of TGFbeta1, which is responsible for an increased production of extracellular matrix (ECM) by various cell types, mainly fibroblasts in injured tissues. Besides the increased expression of ECM, the TGFbeta1 also promotes the inhibition of the degradation processes of the same. The intense expression of this cytokines in irradiated skin can trigger the process of fibrosis and, consequently, affect the homeostasis of the body due to accumulation of ECM.
|
184 |
Role nových profibrotických molekul v patogenezi systémové sklerodermie. / The role of new profibrotic molecules in the pathogenesis of systemic sclerosis.Šumová, Barbora January 2018 (has links)
Systemic sclerosis (SSc) is immune-mediated fibrotic disease of unknown aetiology. Among the dominant pathogenic manifestations of SSc belong vascular changes, production of autoantibodies, activation of innate and adaptive immune responses and fibrotic processes. Transforming growth factor beta (TGF-β) has been identified as a central profibrotic factor stimulating fibroblasts to produce collagen. There are, however, a number of other mediators involved in the pathogenesis of SSc. Mutual activation and amplification of these molecules and their cascades may be a central mechanism of the SSc pathogenesis. Hedgehog (Hh) canonical signalling pathway plays an important role in the development and progression of fibrotic diseases. Expression of Hh target genes can be regulated through a canonical or non-canonical signalling cascade. The non-canonical activation of GLI transcription factors by TGF-β has not yet been investigated in SSc. The substantial part of this thesis is focused on the study of the mutual interaction of TGF-β and Hh signalling pathway. In vitro analysis confirmed TGF- β/SMAD3 dependent activation of GLI2 in dermal fibroblasts. Fibroblasts specific knockout of GLI2 prevented the development of experimental fibrosis in vivo. Combined targeting of canonical and non-canonical Hh...
|
185 |
Caquexia associada ao câncer: a contribuição da via de sinalização do TGFβ na fibrose do tecido adiposo. / Cancer cachexia: TGFβ pathway contribution in adipose tissue fibrosis.Michele Joana Alves 13 July 2016 (has links)
O objetivo do estudo foi investigar o remodelamento tecidual e fatores modulados pela via do TGFβ no tecido adiposo subcutâneo na vigência da caquexia associada ao câncer gastrointestinal. O estudo incluiu 59 pacientes divididos em três grupos: Controle, Câncer de peso estável (WSC) e Câncer e Caquexia (CC). Foram observadas alterações morfológicas exclusivas ao tecido adiposo do grupo CC. Houve o aumento na deposição de colágeno, glicoproteínas associadas, e fibras do sistema elásticas. A imunohistoquímica revelou alterações no conteúdo dos colágenos do tipo I, III e VI, e da fibronectina no grupo CC em relação ao grupo Controle e WSC. A presença de miofibroblastos no grupo CC foi confirmada pela imunomarcação para αSMA, e o aumento de 20 vezes do gene FSP1 no tecido adiposo, em associação com expressiva marcação de vimentina em fibroblastos isolados. As concentrações do TGFβ3 estavam aumentadas no tecido adiposo, e TGFβ1 e TGFβ3 nos adipócitos, dos pacientes caquéticos. A imunolocalização revelou maior intensidade para SMAD3 e SMAD4 no grupo CC. Em conclusão, na caquexia associada ao câncer, a via do TGFβ contribui para o comprometimento da biologia do tecido adiposo e o desenvolvimento da fibrose. / Aim of the study was to investigate tissue remodelling and factors modulated by TGFβ pathway in the subcutaneous adipose tissue in gastrointestinal cancer cachexia. The study included 59 patients enrolled into three groups: Control, Weight-stable Cancer (WSC) and Cancer Cachexia (CC). Morphological alterations (HE) were observed in adipose tissue from CC group solely, with reduction in the content of fat cells (area, diameter and circumference). Markedly stain to collagens type I, III, IV and fibronectin by immunohistochemistry revealed changes in the CC group as compared to the control and WSC group. Presence of myofibroblasts in CC group was observed by immunostaining for αSMA, and 20-fold increase of the FSP1 gene in adipose tissue. In association, was reported higher expression for vimentin in isolated fibroblasts. TGFβ3 concentrations were enhanced in adipose tissue, and TGFβ1 and TGFβ3 in adipocytes of cachectic patients in relation to control group. Immunolocalization revealed greater intensity for SMAD3 and SMAD4 in the CC group. Thus, during cancer cachexia the TGFβ pathway contributes to disruption of adipose tissue biology and fibrosis development.
|
186 |
Tabhys: um peptídeo com atividade lectínica extraído de Tabernaemontana hystrix / Tabhys: a peptide with lectin activity extracted from Tabernaemontana hystrixGabriela Peron 31 August 2015 (has links)
Lectinas são proteínas que possuem pelo menos um domínio não catalítico que se liga reversível e especificamente a um monossacarídeo ou oligossacarídeo. A capacidade de ligação a diferentes tipos de açúcares torna essas moléculas ferramentas úteis no estudo de diversos processos celulares específicos. Embora as lectinas de plantas sejam amplamente estudadas, aquelas referentes à família Apocynaceae ainda são pouco exploradas. Resultados prévios obtidos pelo nosso grupo de pesquisa mostraram que extratos brutos de súber do caule da apocinácea Tabernaemontana hystrix Steud apresenta atividade hemaglutinante. Além de aglutinar eritrócitos do sistema ABO, a putativa aglutinina foi capaz de estimular a síntese de RNAm de IL-6 e TGF- beta em células esplênicas de camundongos. À vista disso, no presente projeto tivemos como objetivo identificar, caracterizar bioquimicamente e avaliar o possível potencial imunoestimulador da aglutinina de T. hystrix. Os extratos de T. hystrix obtidos por meio da farinha de raspas do súber apresentaram atividade hemaglutinante, o que não foi observado no extrato do caule destituído de súber e no extraído das folhas. Para comprovar que se tratava da atividade observada anteriormente, obtivemos a inibição da hemaglutinação com a glicoproteína fetuína, mas não houve inibição por monossacarídeos. Foi determinado um protocolo de isolamento da hemaglutinina com precipitação do extrato do súber com sulfato de amônio, cuja atividade foi recuperada no material precipitado na faixa de 30 a 60% de saturação, seguido de cromatografias sequenciais por (1) interação hidrofóbica (HiTrap Octyl), (2) troca catiônica (HiTrap SP), (3) fase reversa (EC Nucleosil C18) e (4) afinidade (Blue Sepharose). Nessas colunas a atividade foi recuperada do (1) material não retido e dos eluatos (2 e 4) com 1M e 0,5M de NaCl, respectivamente, e (3) 83% de acetonitrila. Esse protocolo produziu uma preparação homogênea contendo um peptídeo cuja análise eletrofóretica revelou massa molecular (MM) aproximada de 3kDa e concentração hemaglutinante mínima de 50g/mL. A fim de determinar se esse peptídeo formava estrutura quaternária (dímeros, tetrâmetros, etc.), característica da maioria das lectinas de plantas, submeteu-se a preparação a uma eletroforese em gel nativo (PAGE), não sendo observadas mudanças na MM do peptídeo e nem a presença de outras moléculas com MM maiores que pudessem estar associadas a ele, o que sugere que a aglutinina de T. hystrix (denominado aqui de Tabhys) é um peptídeo de MM aproximada de 3kDa. O fato da heveína, um dos peptídeos lectínicos com atividade antifúngica mais estudado, ter especificidade por quitina nos motivou a tentar o isolamento do peptídeo em coluna desse polissacarídeo. Observou-se atividade hemaglutinante e presença de peptídeo com MM de 3kDa no material eluído com Ácido acético a 0,1M da coluna de quitina. Curiosamente, nenhuma de nossas preparações foram capazes de inibir o crescimento do fungo Trichophyton rubrum. O peptídeo purificado foi testado quanto a sua capacidade em induzir a proliferação celular e a produção de citocinas em células esplênicas murinas. Os resultados dos ensaios de RT-PCR em tempo real e citometria de fluxo demonstraram que o a aglutinina de T. hystrix não foi capaz de estimular a proliferação de linfócitos, entretanto, induziu o aumento de mensagem para a citocina TGF-beta, cujo pico de produção ocorreu em célula estimuladas com 37ng/mL. Neste estudo, relatamos a presença de um peptídeo no extrato de T. hystrix com atividade hemaglutinante, o que é relativamente raro e novo. Devido a isso, este estudo pode proporcionar novas perspectivas e paradigmas nos estudos das lectinas a nível molecular e estrutural. / Lectins are proteins that have at least one non-catalytic domain that binds specifically and reversibly to a monosaccharide or oligosaccharide. This ability to bind to different types of sugars makes these molecules useful tools in the study of various specific cellular processes. Although the plant lectins are widely studied, those belong to Apocynaceae family are still little explored. Previous results obtained by our research group showed that bark crude extracts from Tabernaemontana hystrix Steud (Apocynaceae) had hemagglutination activity. Besides to agglutinate erythrocytes from ABO blood group system, the putative agglutinin induced the synthesis of IL-6 and TGF-beta mRNA in mouse spleen cells. Here we aim to identify, characterize biochemically and evaluate the possible immunostimulatory potential of T. hystrix agglutinin. The haemagglutination activity was obtained from crude extracts of bark flour, but not of flours of stems without bark and leaves. The activity of the bark extract was similar to that from the previous study, since the haemagglutination was inhibited by the glycoprotein fetuin, but not by monosaccharides. An isolation protocol was determined by using ammonium sulfate precipitation, with haemagglutination activity recovered in the range of 30-60% of saturation, and sequential chromatography procedures: (1) hydrophobic interaction (HiTrap Octyl), (2) cation-exchange (HiTrap SP), (3) reverse phase (EC Nucleosil) and (4) affinity (BlueSepharose) chromatography. From these columns the activity was recovered in the (1) unbound material, and eluates (2 and 4) with 1M and 0,5M of NaCl, respectively, and (3) 83% acetonitrile. On the basis of electrophoresis analysis, the protocol produced a preparation comprised of only band corresponding a peptide with molecular weight (MW) of about 3-kDa, with minimum haemagglutination concentration of 50g/ml. To determine if this molecule arrangement had a quaternary structure arrangement, a feature of most known lectins, we submitted the preparation to a native electrophoresis. Because there was neither change in migration pattern nor presence of molecules of higher molecular mass, we suggested that T. hystrix peptide (Tabhys) is a peptide with MW of about 3-kDa. Since hevein, which is a most studied lectin-like peptide with antifungal activity, binds specifically to chitin, we performed an affinity chromatography in the chitin column with bark extract. We observed haemagglutination activity and the presence of peptide with MW of 3-kDa in the material bound to column and eluted with 0,1M acetic acid. Curiously, this peptide was not able to inhibit the growth of the fungus Trichophyton rubrum. Thereafter, when the purified peptide was used to stimulate murine spleen cells, we detected the expression of TGF-beta message, with a peak production obtained in cell stimulated with 37 ng/mL of Tabhys. In the current study, we isolated a peptide from crude extract of T. hystrix bark with haemagglutination activity, providing new perspectives in molecular and structural researches of peptide lectins.
|
187 |
Expressão de fator de crescimento transformador Beta e inibidores teciduais de metaloproteinases 1 e 2 em próstatas caninas normais e com lesões proliferativas / Expression of tansforming growth factor B and tissue inhibitor of metalloproteianse 1 and 2 in normal canine prostates and with proliferative lessionsTOLEDO, Denise Caroline 08 March 2012 (has links)
Made available in DSpace on 2014-07-29T15:07:41Z (GMT). No. of bitstreams: 1
Dissertacao_Denise C Toledo.pdf: 1395118 bytes, checksum: 592dff1a4d2ff80089be7e8691c93893 (MD5)
Previous issue date: 2012-03-08 / The canine gland has drawn interest for research due to its similarities with the human prostate and the great incidence of lesions. Moreover, the canine prostate shows high incidence of diseases. The main lesions that affect the prostate are prostatitis, benign prostatic hyperplasia (BPH), cysts and adenocarcinoma. Recently attention has been given to lesions considered premalignant such as prostatic intraepithelial neoplasia (PIN) and proliferative inflammatory atrophy (PIA), both studied in the human gland and also found in the canine prostate. In order to evaluate the development of prostate cancer starting as premalignant lesions, some immunohistochemical markers are employed, such as tissue inhibitors of metalloproteinases (TIMP), which have a key role in regulating the catalytic action of metalloproteinases (MMP), and transforming growth factor-β (TGF-β), that induces angiogenesis and inhibits cell proliferation and is considered a mediator of prostate growth. The objective of this study was to investigate the expression of TIMP-1, TIMP-2 and TGF-β in canine normal prostate tissue and with proliferative lesions. For this, 150 adult canine prostates were obtained from postmortem examinations. After microscopic evaluation 54 glands, compatible with normal, epithelial BPH, stromal BPH, PIA, PIN and adenocarcinoma were selected and used to make tissue microarray block (Tissue Microarray - TMA). TMA slides were subjected to immunohistochemistry with anti-TIMP-1, anti-TIMP-2 and anti-TGF-β, to assess staining intensity of epithelial cells and stromal cells.Cytoplasmatic staining of canine prostate cells by TIMP-1, TIMP-2 and TGF-β was observed, with TIMP-1 and TIMP-2 being more expressed in premalignant and malignant lesions, while TGF-β was expressed mainly by normal tissue and BPH. Furthermore, there were differences in the expression between epithelial and stromal cells. / A próstata canina, além das similaridades com a próstata humana, apresenta grande incidência de afecções. As principais lesões que acometem a próstata são as prostatites, a hiperplasia prostática benigna (HPB), os cistos e o adenocarcinoma, sendo que, recentemente, se tem dado atenção às lesões consideradas pré-malignas, como a neoplasia intraepitelial prostática (PIN) e a atrofia inflamatória proliferativa (PIA), ambas estudadas na glândula humana, e também verificadas na próstata do cão. Para avaliar o desenvolvimento de neoplasias prostáticas a partir das lesões pré-malignas, alguns marcadores imunoistoquímicos são empregados, como os inibidores teciduais de metaloproteinases (TIMP), que apresentam importante função na regulação da ação catalítica das metaloproteinases (MMP), e o fator de crescimento transformador β (TGF-β), que induz a angiogênese e inibe a proliferação celular, sendo considerado um mediador do crescimento prostático. O objetivo deste estudo foi verificar a expressão de TIMP-1, TIMP-2 e TGF-β no tecido prostático canino normal e com lesões proliferativas. Para isso foram colhidas, em exames necroscópicos, 150 próstatas de cães adultos e idosos. O material foi avaliado histologicamente e selecionadas amostras de 54 próstatas com predominância de histomorfologia normal, HPB epitelial, HPB estromal, PIA, PIN e adenocarcinoma, que foram utilizadas para a confecção de um bloco de microarranjo tecidual (Tissue Microarray - TMA). As lâminas de TMA foram submetidas à imunoistoquímica com os anticorpos anti-TIMP-1, anti-TIMP-2 e anti-TGF-β, sendo avaliada a intensidade de marcação das células epiteliais e estromais. Verificou-se que há marcação citoplasmática das células prostáticas caninas para TIMP-1, TIMP-2 e TGF-β, sendo as proteínas TIMP-1 e TIMP-2 mais expressas nas lesões proliferativas pré-malignas e malignas, enquanto TGF-β foi expresso principalmente pelo tecido normal e com HPB epitelial e estromal. Ainda, houve diferença de marcação entre células epiteliais e estromais.
|
188 |
Avaliação da expressão salivar e tecidual das citocinas TGF-β e IL-10 em pacientes com carcinoma espinocelular de cavidade oral / Evaluation of saliva and tissue expression of TGF-β and IL-10 in patients with oral squamous cell carcinomaArantes, Diego Antonio Costa 02 March 2015 (has links)
Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2015-05-25T15:45:53Z
No. of bitstreams: 2
Dissertação - Diego Antônio Costa Arantes - 2015.pdf: 5243498 bytes, checksum: 85643aafc3a6a4e6090981926b875c7f (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-05-25T15:48:09Z (GMT) No. of bitstreams: 2
Dissertação - Diego Antônio Costa Arantes - 2015.pdf: 5243498 bytes, checksum: 85643aafc3a6a4e6090981926b875c7f (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-05-25T15:48:09Z (GMT). No. of bitstreams: 2
Dissertação - Diego Antônio Costa Arantes - 2015.pdf: 5243498 bytes, checksum: 85643aafc3a6a4e6090981926b875c7f (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Previous issue date: 2015-03-02 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEG / The transforming growth factor β (TGF-β) and interleukin 10 (IL-10) are
immunosuppressive cytokines which promote failure of the local anti-tumor immune
response and, therefore, influence the proliferation and prognosis of malignant neoplasms.
The aim of this study was to investigate the tissue and salivary expression of TGF-β and
IL-10 in patients with oral squamous cell carcinoma (OSCC) and compare it with that of
healthy subjects (Control). The association of these cytokines with clinical parameters of
prognosis (staging, metastasis and survival) and histological grade of malignancy (WHO
grading) was also investigated. Cytokines in the tissue (OSCC, n = 65; Control, n = 30)
were identified using the immunohistochemistry technique (IHC) and in the saliva (OSCC,
n = 22; Control, n = 23) the Enzyme-linked Immunosorbent Assay (ELISA) was used. The
tissue expression of TGF-β and IL-10 in metastatic lymph nodes (n = 23) of OSCC
patients was investigated. The expression of TGF-β and IL-10 in the tissue was measured
using a semi-quantitative method in conjunction with staining intensity. Our findings
demonstrated a high tissue expression of IL-10 and TGF-β2, and a low or absent
expression of TGF-β1, in the majority of OSCC samples when compared to the group with
clinically healthy oral mucosa (Control) (p < 0.05 for IL-10 and TGF-β2). The salivary
concentration of IL-10 was also high, and distinguished the OSCC patients from their
healthy counterparts (p = 0.04), while the salivary concentration of TGF-β1 was similar for
both the OSCC and control groups (p = 0.97). The relationship between the cytokine
expression and clinical and microscopic prognostic factors showed that the expression of
IL-10 and TGF-β2 in neoplastic cells of the primary tumor was maintained by the
metastatic neoplastic cells in the cervical lymph nodes. The expression of TGF-β1
remained low or absent in the metastatic lymph nodes. It was shown that there was an
association between the high expression of IL-10 by tumor cells and the advanced clinical
stages (T3-T4) of patients (p = 0.02). Although not statistically significant, the expression
of TGF-β2 was higher in tumors at more advanced stages (p > 0.05). These findings
demonstrate that OSCC provides an immunosuppressive environment conducive to tumor
proliferation, with high expression of IL-10 and TGF-β2, which contributes to a worse
clinical prognosis. In addition, of the immunosuppressive cytokines investigated, IL-10 has
greater potential for becoming salivary biomarker when associated with an unfavorable
clinical prognosis of OSCC patients. / Fator de crescimento transformador β (TGF-β) e interleucina 10 (IL-10) são citocinas
imunossupressoras que propiciam a falha da resposta imune anti-tumoral local e
influenciam, assim, na progressão e prognóstico de neoplasias malignas. O objetivo deste
estudo foi investigar a expressão tecidual e salivar de TGF-β e IL-10 em pacientes com
carcinoma espinocelular de cavidade oral (CECO) e comparar essa expressão com
aquela dos indivíduos saudáveis (Controle). A associação dessas citocinas com
parâmetros clínicos de prognóstico (estadiamento, metástase e sobrevida) e grau
histológico de malignidade (segundo a OMS) também foi investigado. A identificação das
citocinas no tecido (CECO - n= 65 e Controle - n=30) foi feita pela técnica de imunohistoquímica
(IHC) e na saliva (CECO - n=22 e Controle - n=23) pelo ensaio
imunoenzimático (ELISA). A expressão tecidual de TGF-β e IL-10 em linfonodos
metastáticos (n= 23) de pacientes com CECO foi investigada. No tecido, a expressão de
TGF-β e IL-10 foi mensurada por método semi-quantitativo associada à intensidade de
marcação. Nossos achados demonstraram uma alta expressão tecidual de IL-10 e TGF-
β2 e, baixa ou ausente expressão de TGF-β1, na maioria das amostras de CECO se
comparada ao grupo de mucosa oral clinicamente saudável (Controle) (P<0,05 para IL-10
e TGF-β2). A concentração salivar de IL-10 também foi elevada e distinguiu o paciente
com CECO dos indivíduos saudáveis (P= 0,04). Já a concentração salivar de TGF-β1 foi
similar entre o grupo de paciente com CECO e o controle (P= 0,97). A relação da
expressão das citocinas com fatores clínicos e microscópicos de prognóstico revelou que
a expressão de IL-10 e TGF-β2 nas células neoplásicas do tumor primário foi mantida
pelas células neoplásicas metastáticas nos linfonodos cervicais. A expressão de TGF-β1
se manteve baixa ou ausente em linfonodos mestastáticos. Associação entre alta
expressão de IL-10 pelas células neoplásicas e o estadiamento clínico avançado (T3-T4)
dos pacientes foi evidenciada (P=0,02). Embora sem diferença estatística, a expressão de
TGF-β2 foi maior nos tumores em estágios mais avançados (P>0,05). Esses achados
demonstram que o CCEO possui um ambiente imunossupressor propício para progressão
tumoral, com elevada expressão de IL-10 e TGF-β2, o qual contribui para um pior
prognóstico clínico dos pacientes. Além disso, das citocinas imunosupressoras
investigadas, a IL-10 apresenta maior potencial para se tornar um biomarcador salivar
associado ao prognóstico clínico desfavorável do paciente com CECO.
|
189 |
Encapsulation de protéines dans des systèmes polymériques particulaires par des procédés sans solvants toxiques pour l'ingénierie tissulaire du cartilage / Protein encapsulation into polymeric particulate systems using non-toxic solvents for cartilage tissue engineeringSwed, Amin 10 July 2015 (has links)
Ce travail a été mené afin de développer des systèmes polymériques particulaires chargés en facteur de croissance (TGF-β1) en vue d’une application à l’ingénierie tissulaire du cartilage. Tout d’abord, des nanoparticules d’acide poly(lactique-co-glycolique) (PLGA) ont été générées par un procédé basé sur la séparation de phase. De plus, des microparticules de PLGA ont été formées à l’aide d’un procédé d’émulsification/extraction du solvant en milieu CO2 pressurisé. L’un des avantages de ces procédés de formulation est l’utilisation de solvants injectables, non toxiques et non volatils. Les systèmes polymériques préparés ont été caractérisés et des particules sphériques à libération contrôlée ont été obtenues avec un rendement d’encapsulation satisfaisant tout en préservant l’activité biologique du facteur de croissance. Les particules chargées en TGF-β1 ont ensuite été incorporées dans un hydrogel injectable à base d’un dérivé cellulosique silanisé (Si-HPMC) contenant des cellules souches. Le biomatériau obtenu a été caractérisé en termes de morphologie, de propriétés rhéologiques et pour sa capacité à libérer le facteur de croissance. La libération contrôlée et localisée du TGF-β1 pourrait induire la survie, la prolifération ainsi que la différenciation chondrocytaire des cellules souches associées ce qui contribuerait à la régénération du cartilage. En conclusion, le biomatériau hybride élaboré au cours de ce travail possède un potentiel prometteur pour l’ingénierie tissulaire du cartilage. / The aim of this work is to develop polymeric particulate systems loaded with transforming growth factor (TGF-β1) for cartilage tissue engineering application. First, nanoparticles of PLGA (poly(lactic-co-glycolic) acid) were generated using a phase separation method while PLGA microparticles were prepared by an emulsification/extraction process in CO2 medium. Interestingly, non-toxic, non-volatile injectable solvents were used in the formulation processes. The prepared polymeric systems were characterized; spherical particles with sustained release were obtained and satisfactory encapsulation efficiency was achieved with preservation of the growth factor bioactivity. TGF-β1-loaded particles were then incorporated within injectable silanized cellulose-based hydrogel (Si-HPMC) containing stem cells. The obtained biomaterial was characterized in terms of morphology, rheological properties and release study. The local and sustained release of TGF-β1 could induce survival, proliferation and differentiation of stem cells into chondrocytes which may promote cartilage regeneration. To conclude, the elaborated hybrid biomaterial has a promising potential for cartilage tissue engineering.
|
190 |
Rôle de la Ténascine-X dans l’activation du TGF bêta latent / Role of Tenascin-X in latent TGF beta activationAlcaraz, Lindsay 09 September 2015 (has links)
La Ténascine-X (TNX) est une glycoprotéine architecturale de la matrice extracellulaire. Outre ce rôle, la TNX est également considérée comme une protéine matricellulaire qui est capable de réguler le comportement de cellules normales et tumorales. Toutefois, aucun mécanisme moléculaire et cellulaire ne permettait d'expliquer les effets cellulaires de la TNX, avant notre étude. Au laboratoire, nous avons démontré que le domaine C-terminal de type fibrinogène (FBG) de la TNX était capable d'induire l'activation du Transforming Growth Factor (TGF) bêta latent. En effet, les trois isoformes du TGF bêta sont sécrétées sous la forme de complexes inactifs formés à partir de liaisons non covalentes entre le TGF bêta mature et son propeptide N-terminal LAP (Latency Associated Peptide). Nous avons montré que le domaine FBG de la TNX interagissait physiquement avec le TGF bêta latent, in vitro et in vivo, et induisait un changement de conformation du complexe latent, afin de permettre son activation en une molécule bioactive. De plus, nous avons identifié l'intégrine alpha11 bêta1 comme un récepteur membranaire pour la TNX et nous avons montré que cette intégrine était cruciale pour le processus d'activation du TGF bêta latent par le domaine FBG. Nous avons également démontré que les Méprines alpha et bêta deux protéases de la famille des astacines, pouvaient cliver la TNX, permettant ainsi de libérer des fragments contenant le domaine FBG, capables d'activer le TGF bêta latent. Enfin, nous avons entamé une étude de la pertinence biologique de l'activation du TGF bêta latent par la TNX in vivo en analysant la voie de signalisation du TGF bêta dans des souris déficientes ou non en TNX / Tenascin-X (TNX) is an architectural glycoprotein of the extracellular matrix. Beyond this role, TNX is also considered as a matricellular protein that is able to regulate the behavior of normal and tumor cells. However, no molecular and cellular mechanism has been described to explain TNX cellular effects before our study. In the laboratory, we showed that the C-terminal fibrinogen-like domain (FBG) of TNX was able to induce the latent transforming growth factor (TGF beta activation. Indeed, the three TGF beta isoforms are secreted as inactive complexes formed from non-covalent bonds between the mature TGF beta and its N-terminal propeptide, called LAP (Latency Associated Peptide). We showed that the FBG domain of TNX physically interacted with the latent TGF beta, in vitro and in vivo, and induced a conformational change of the latent complex to allow its activation into a bioactive molecule. Furthermore, we identified alpha1 beta1 integrin as a cell-surface receptor for TNX and showed that this integrin was crucial for the FBG-induced latent TGF beta activation. We also demonstrated that Meprins alpha and beta, two proteases belonging to the astacin family, could cleave the TNX, thereby releasing fragments containing the FBG domain capable of activating latent TGF beta. Finally, we have initiated a study regarding the biological relevance of latent TGF beta activation by TNX in vivo by analyzing the TGF beta signaling pathway in wild type or TNX-deficient mice
|
Page generated in 0.0667 seconds